Skip to main content

Activist investor Carl Icahn sued Dell Technologies on Thursday, alleging that the computer maker did not disclose financial information related to its plans to go public by buying back its tracking stock.

Icahn, who owns 9.3 per cent of Dell, called the proposed deal a “conflicted transaction that benefits the controlling stockholders, at the expense of the DVMT stockholders.”

Dell said in July it would pay $21.7 billion in cash and stock to buy back shares tied to its interest in software company VMware Inc, returning it to the stock market without an initial public offering.

Story continues below advertisement

Icahn and other hedge fund investors have resisted the plan, saying the proposed deal massively undervalues the tracking stock.

“We believe this is a threat blatantly deployed in an attempt to coerce DVMT stockholders to vote in favour of the merger, or else risk the unknown consequences of the forced IPO conversion,” Icahn said on Thursday, urging investors to vote against the deal.

Icahn is no stranger to lawsuits. He sued AmTrust Financial Services earlier this year over its go-private plans.

The investor also turned legal arguments against Dell in the past, having alleged that Michael Dell and Silver Lake undervalued the company’s go-private deal several years ago.

Icahn, along with investor Darwin Deason, also urged Xerox Corp shareholders earlier this year to oppose a sale to Japan’s Fujifilm Holdings.

Dell declined to comment, while Icahn did not immediately respond to requests for comment.

Related topics

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies